DeepMed Research

SUN YAT-SEN MEMORIAL HOSPITAL,SUN YAT-SEN UNIVERSITY

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Temporal Diffusion Spectroscopy MRI in Predicting the CPS of PD-L1 Expression and the Efficacy of Neoadjuvant Therapy

Recruiting

Conditions: Head and Neck Squamous Cell Carcinoma
Neoadjuvant Therapy
Magnetic Resonance Imaging

First Posted Date: 2023-07-28

Last Posted Date: 2023-07-28

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 136

Registration Number: NCT05964595

Locations: 🇨🇳
Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China

Effect of Early Extracorporeal Diaphragm Pacing Combined With Tilt Table in Ventilated Patients.

Not Applicable

Not yet recruiting

Conditions: Diaphragm Dysfunction
Early Mobilization
Critically Ill
Mechanical Ventilation

Interventions: Device: Extracorporeal Diaphragm Pacing
Other: Conventional Physiotherapy
Device: Tilt Table Verticalization

First Posted Date: 2023-07-20

Last Posted Date: 2023-07-20

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 90

Registration Number: NCT05953649

A Phase Ib/II Study Confirmed Inhibition of Autophagy Synergizes Anti-tumor Effect of High Dose CDK4/6i

Phase 1

Recruiting

Conditions: Inhibition of Autophagy Synergizes Anti-tumor Effect

Interventions: Drug: 600mg bid dose of hydroxychloroquine combined with three predefined dose groups of palbociclib
Drug: RP2D dose of 600mg bid of hydroxychloroquine combined with palbociclib was selected for phase II clinical trial.

First Posted Date: 2023-07-20

Last Posted Date: 2024-12-03

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 29

Registration Number: NCT05953350

Locations: 🇨🇳
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China

Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein Purpura

Not Applicable

Recruiting

Conditions: Henoch-Schönlein Purpura
Mycophenolate Mofetil
Gastrointestinal Injury

Interventions: Drug: MMF

First Posted Date: 2023-07-19

Last Posted Date: 2023-07-19

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 24

Registration Number: NCT05951517

Locations: 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

A Retrospective Study Reveals the Relationship Between gp42-IgG Epitopes and EBV-associated NPC

Recruiting

Conditions: Nasopharyngeal Carcinoma

Interventions: Diagnostic Test: Epitope exploration

First Posted Date: 2023-07-18

Last Posted Date: 2023-09-06

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 1000

Registration Number: NCT05949749

Locations: 🇨🇳
Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China

A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC

Phase 2

Recruiting

Conditions: HER2-positive Breast Cancer

Interventions: Drug: Eribulin mesylate injection、Pertuzumab、Trastuzumab

First Posted Date: 2023-07-14

Last Posted Date: 2023-07-14

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 78

Registration Number: NCT05945368

Locations: 🇨🇳
LI YuDong, Guanzhou, Guangdong, China

Tirelizumab in Combination With Carboplatin and Albumin-binding Paclitaxel for Neoadjuvant Therapy in HNSCC

Phase 2

Recruiting

Conditions: Head and Neck Squamous Cell Carcinoma
Oral Cancer

Interventions: Drug: Tirelizumab ,+Carboplatin+albumin-bound paclitaxel

First Posted Date: 2023-07-12

Last Posted Date: 2023-07-12

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 100

Registration Number: NCT05941338

Locations: 🇨🇳
Sun yat-sun memorial hospital, Guangzhou, Guangdong, China

Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children

Phase 1

Recruiting

Conditions: Idiopathic Pulmonary Hemosiderosis
Leflunomide

Interventions: Drug: Steroid Drug
Drug: Leflunomide

First Posted Date: 2023-07-10

Last Posted Date: 2023-07-10

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 34

Registration Number: NCT05937191

Locations: 🇨🇳
Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

Leflunomide for Henoch-Schonlein Purpura

Not Applicable

Recruiting

Conditions: Henoch-Schonlein Purpura

Interventions: Drug: Leflunomide

First Posted Date: 2023-07-10

Last Posted Date: 2023-07-10

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 36

Registration Number: NCT05937880

Locations: 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

Study of the Therapeutic Effects of Naohuan Dan and Idebenone in Treating Mild Cognitive Impairment With Kidney Deficiency and Phlegm Stasis

Completed

Conditions: Mild Cognitive Impairment

Interventions: Drug: Idebenone
Drug: Naohuan Dan and Idebenone

First Posted Date: 2023-07-05

Last Posted Date: 2023-07-05

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 64

Registration Number: NCT05931029

Locations: 🇨🇳
Sun Yat-sen Memorial Hospital，Sun Yat-sen University，Guangzhou 510300，China, Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy